Sexually transmitted and blood-borne infections: Indicator framework: Quick stats
Overview of 25 indicators of key sexually transmitted and blood-borne infections (STBBIs) in Canada.
- Last updated: 2025-06-12
The STBBI indicators are based on the latest data available, and are grouped in 4 categories:
- Human Immunodeficiency Virus (HIV)
- Bacterial sexually transmitted infections
- Hepatitis C virus
- Human Papillomavirus (HPV) and hepatitis B virus
To view the 2023 quick stats for these STBBIs, click the category of interest below. This will reveal the indicators, sources, latest data, and a link to a description. If you select the description, a table will show background information, context, how the indicator was calculated and other information.
HIV indicators
| Indicators | Latest data | Source (and year published) | Description |
|---|---|---|---|
| Estimated number of people living with HIV (PLHIV) | In 2020, an estimated 62,790 people were living with HIV (undiagnosed and diagnosed) in Canada. | Estimates of HIV incidence, prevalence and Canada's progress on meeting the 90-90-90 HIV targets, 2020. (2022) | Description |
| Estimated percentage of people living with HIV who are diagnosed | An estimated 90% of people living with HIV in Canada had been diagnosed by the end of 2020. | Estimates of HIV incidence, prevalence and Canada's progress on meeting the 90-90-90 HIV targets, 2020. (2022) | Description |
| Estimated percentage of people diagnosed with HIV who are on antiretroviral therapy (ART) | An estimated 87% of people diagnosed with HIV in Canada were on ART by the end of 2020. | Estimates of HIV incidence, prevalence and Canada's progress on meeting the 90-90-90 HIV targets, 2020. (2022) | Description |
| Estimated percentage of people on ART who had a suppressed viral load | In 2020, an estimated 95% of people on treatment in Canada had a suppressed viral load. | Estimates of HIV incidence, prevalence and Canada's progress on meeting the 90-90-90 HIV targets, 2020. (2022) | Description |
| Number and rate of reported first-time HIV diagnoses | 1,472 newly diagnosed cases of HIV were reported in Canada in 2021, which is a rate of 3.8 per 100,000 population. | HIV in Canada: 2021 surveillance highlights (2022)HIV in Canada: 2021 surveillance highlights | Description |
| Estimated number and rate of new HIV infections | An estimated 1,520 new HIV infections occurred in Canada in 2020, which is a rate of 4 per 100,000 population. | Estimates of HIV incidence, prevalence and Canada's progress on meeting the 90-90-90 HIV targets, 2020. (2022) | Description |
| Estimated rate of people using pre-exposure prophylaxis (PrEP) | An estimated 89 people per 100,000 population used PrEP in 2022. | Trends in HIV Pre-Exposure Prophylaxis [HIV-PrEP] use in 9 Canadian provinces, 2019 – 2022 (2023) | Description |
| Number of infants with confirmed perinatal HIV infection | 2 infants were confirmed to be perinatally infected with HIV in 2021. | HIV in Canada: 2021 surveillance highlights (2022) | Description |
| Of the infants perinatally infected with HIV, number born to mothers who received ART | None of the infants who were perinatally infected with HIV in 2021 were born to mothers who received “any” ART treatment. | HIV in Canada: 2021 surveillance highlights (2022) | Description |
Bacterial sexually transmitted infection (STI) indicators
| Indicators | Latest data | Source (and year published) | Description |
|---|---|---|---|
| Number and rate of reported cases of confirmed early congenital syphilis | 117 cases of early congenital syphilis were reported in 2022, for a rate of 31.7 cases per 100,000 live births. | Infectious syphilis and congenital syphilis in Canada, 2022 | Description |
| Number and rate of reported cases of infectious syphilis (primary, secondary, early latent and infectious neurosyphilis) | 13,953 cases of infectious syphilis were reported in Canada in 2022, for a rate of 36.1 cases per 100,000 population. | Infectious syphilis and congenital syphilis in Canada, 2022 (2023) | Description |
| Number and rate of reported gonorrhea cases | 32,192 cases of gonorrhea were reported in Canada in 2021, for a rate of 84.2 cases per 100,000 population. | Chlamydia, gonorrhea and infectious syphilis in Canada: 2021 surveillance data update (2023) | Description |
| Number and rate of reported chlamydia cases | 104,426 cases of chlamydia were reported in Canada in 2021, for a rate of 273.2 cases per 100,000 population. | Chlamydia, gonorrhea and infectious syphilis in Canada: 2021 surveillance data update (2023) | Description |
| Proportion of gonorrhea cultures in Canada resistant to an antimicrobial/antibiotic from the preferred and alternate treatments recommended by PHAC (azithromycin, cefixime and ceftriaxone) | Of gonorrhea cultures tested in 2021:
|
Antimicrobial susceptibilities of Neisseria gonorrhoeae, 2021 (2022) | Description |
| Proportion of gonorrhea cases* reported to the Enhanced Surveillance of Antimicrobial-resistant Gonorrhea (ESAG) system who were prescribed a PHAC recommended gonorrhea treatment regimen *Only includes those ESAG cases that had both a gonococcal culture and were prescribed gonorrhea treatment as reported by Alberta, Manitoba, Nova Scotia and Northwest Territories public health agencies. |
From 2015 to 2020, the mean annual proportion of ESAG cases prescribed a PHAC recommended (preferred or alternative) gonorrhea treatment regimen among gay, bisexual and other men who have sex with men (gbMSM) who had a primary anogenital gonococcal infection was 94.2% (range: 89.1% to 97.7%). The mean annual proportion was similar among gbMSM with a primary pharyngeal infection site, 92.9% (range: 88.9% to 95.8%). Among "other adults" (heterosexual males, females, and transgender people) with anogenital and pharyngeal infections, the mean annual proportion who were prescribed a recommended gonorrhea treatment regimen was 93.6% (range: 91.1% to 96.1%) and 88.4% (range: 76.8% to 96.8%), respectively. | Canadian Antimicrobial Resistance Surveillance System (CARSS) Report 2022 | Description |
Hepatitis C indicators
| Indicators | Latest data | Source (and year published) | Description |
|---|---|---|---|
| Estimated percentage of people living with hepatitis C who have been diagnosed | An estimated 76% of people living with hepatitis C by the end of 2019 had been diagnosed. | National Hepatitis C estimates: Incidence, prevalence, undiagnosed proportion and treatment, Canada, 2019 (2022) | Description |
| Number and rate of reported hepatitis C cases | In 2020, 6,736 cases of hepatitis C (acute, chronic, and unspecified) were reported from 12 provinces and territories, for a rate of 18.4 hepatitis C cases per 100,000 population. | Hepatitis C in Canada: 2020 surveillance data update (2023) | Description |
| Estimated number and rate of new hepatitis C infections | In 2019, it was estimated that 9,470 people acquired hepatitis C infections, for an estimated rate of 25 new hepatitis C infections per 100,000 population. | National Hepatitis C estimates: Incidence, prevalence, undiagnosed proportion and treatment, Canada, 2019 (2022) | Description |
| Estimated number of people living with chronic hepatitis C | In 2019, an estimated 204,000 people were living with chronic hepatitis C. | National Hepatitis C estimates: Incidence, prevalence, undiagnosed proportion and treatment, Canada, 2019 (2022) | Description |
| Estimated number of persons with chronic hepatitis C who have been treated | Direct-acting antivirals were introduced in Canada in 2014 as a treatment and cure for hepatitis C. An estimated 74,500 people living with chronic hepatitis C had been treated by 2019. | National Hepatitis C estimates: Incidence, prevalence, undiagnosed proportion and treatment, Canada, 2019 (2022) | Description |
Hepatitis B and HPV indicators
| Indicators | Latest data | Source (and year published) | Description |
|---|---|---|---|
| Number and rate of reported hepatitis B cases | 3,004 hepatitis B cases were reported in 2020, for a rate of 8.2 per 100,000 population. These included:
|
Hepatitis B in Canada: 2020 surveillance data (2023) | Description |
| Hepatitis B vaccination coverage (%) among 14-year-old children | In 2021, 89% of 14-year-olds in Canada had been vaccinated against hepatitis B. | Childhood National Immunization Coverage Survey (cNICS) 2021 (2021) | Description |
| HPV vaccination coverage (%) among 14-year-old-children | In 2021, 84% of 14-year-olds had been vaccinated against HPV. | Childhood National Immunization Coverage Survey (cNICS) 2021 (2021) | Description |
| Number and rate of reported new cervical cancer cases | In 2017, 1,525 new cases of cervical cancer were reported in Canada, for a rate of 8.3 cases per 100,000 females. | Number and rates of new cases of primary cancer, by cancer type, age group and sex, Statistics Canada (2023) | Description |
You might also be interested in
How has COVID-19 impacted access to STBBI-related health services, including harm reduction services, for African, Caribbean and Black (ACB) people in Canada?
Challenges in delivering healthcare services including sexually transmitted and blood-borne infection (STBBI) prevention during the COVID-19 pandemic.
How has COVID-19 impacted access to STBBI-related health services, including harm reduction services, for people who use drugs or alcohol in Canada
How the COVID-19 pandemic has affected access to sexually transmitted and blood-borne infection (STBBI) prevention, testing and treatment services, and harm reduction services, for people who use drugs or alcohol.
- Date modified: